Anvisa approves Fiocruz import of 2 million doses of vaccine against COVID-19

Anvisa has approved the exceptional import of 2 million doses by Fiocruz of the COVID-19 vaccine developed by AstraZeneca in partnership with Oxford University. The import is considered exceptional because the immunising agent has not yet been submitted for emergency use or sanitary registration, Anvisa said in a statement.

Source: Reuters